The third-generation Connected Health Platform (CHP) from Phillips-Medisize, a Molex company, helps pharmaceutical companies and drug delivery device developers reduce risk, cost and time to market with leading innovation and technology accelerators. This cloud-based platform provides a safe, scalable and trusted medical device data system (MDDS) built on technology from the world leader in health data interoperability. It encompasses extensive information-sharing, analytics capabilities, robust cybersecurity and streamlined regulatory documentation. Its advanced analytics package is designed for connected drug delivery devices, biosensors and regulated Mobile Medical Applications (SaMD/MMA). Ultimately, connected health solutions may help patients improve medication adherence and manage chronic conditions.
Phillips-Medisize Connected Health Platform is assigned to following product groups:
- Design, R&D (220)
- IT (142)
- Processes, Mechanical Engineering, Manufacturing (428)